Huddinge
Sweden
32
2014-05-01
28
2016-10-04
These are the the leading inventors for applications assigned to Tripep AB:
Tripep AB based in Huddinge, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Injection needle and device
#2 | 2014-03-20 ✅ Patent 9,079,962 granted on 2015-07-14Glycosylated specificity exchangers
#3 | 2013-01-10 ✅ Patent 9,193,778 granted on 2015-11-24T cell receptors specific for immunodominant CTL epitopes of HCV
#4 | 2012-10-25 ✅ Patent 9,284,548 granted on 2016-03-15High affinity adaptor molecules for redirecting antibody specifity
#5 | 2010-07-22 ✅ Patent 8,303,956 granted on 2012-11-06Glycosylated specificity exchangers
#6 | 2010-04-29 ✅ Patent 7,943,149 granted on 2011-05-17Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
#7 | 2009-12-10GLYCOSYLATED SPECIFICITY EXCHANGER
#8 | 2009-08-27 ✅ Patent 7,968,697 granted on 2011-06-28Hepatitis C virus non-structural NS3/4A fusion gene
#9 | 2009-08-27IMMUNOGEN PLATFORM
#10 | 2009-07-02INDENTIFICATION OF COMPOUNDS THAT INHIBIT REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS
#11 | 2009-04-09GLYCOSYLATED SPECIFICITY EXCHANGERS THAT INDUCE AN ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) RESPONSE
#12 | 2009-03-19 ✅ Patent 8,071,561 granted on 2011-12-06Immunogen platform
#13 | 2008-11-27 ✅ Patent 7,566,812 granted on 2009-07-28Transgenic mouse models of hepatitis C virus (HCV) and identification of HCV therapeutics
#14 | 2008-09-04 ✅ Patent 7,638,499 granted on 2009-12-29Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
#15 | 2007-08-28 ✅ Patent 7,261,883 granted on 2007-08-28Vaccines containing ribavirin and methods of use thereof
#16 | 2007-07-10 ✅ Patent 7,241,440 granted on 2007-07-10Vaccines containing ribavirin and methods of use thereof
#17 | 2007-02-01 ✅ Patent 7,226,912 granted on 2007-06-05Hepatitis C virus non-structural NS3/4A fusion gene
#18 | 2006-12-07 ✅ Patent 7,332,166 granted on 2008-02-19Glycosylated specificity exchangers
#19 | 2006-08-31 ✅ Patent 7,534,435 granted on 2009-05-19Glycosylated specificity exchangers
#20 | 2006-08-17 ✅ Patent 7,223,743 granted on 2007-05-29Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
#21 | 2006-08-17 ✅ Patent 7,244,715 granted on 2007-07-17Vaccines containing ribavirin and methods of use thereof
#22 | 2006-08-17 ✅ Patent 7,244,422 granted on 2007-07-17Vaccines containing ribavirin and methods of use thereof
#23 | 2006-04-04 ✅ Patent 7,022,830 granted on 2006-04-04Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
#24 | 2006-03-28 ✅ Patent 7,019,111 granted on 2006-03-28Glycosylated ligand/receptor specificity exchangers specific for bacterial adhesion receptors
#25 | 2006-03-23 ✅ Patent 7,439,347 granted on 2008-10-21Hepatitis C virus non-structural NS3/4A fusion gene
#26 | 2006-03-14 ✅ Patent 7,012,129 granted on 2006-03-14Antiviral composition comprising glycine amide
#27 | 2005-11-01 ✅ Patent 6,960,569 granted on 2005-11-01Hepatitis C virus non-structural NS3/4A fusion gene
#28 | 2005-08-23 ✅ Patent 6,933,366 granted on 2005-08-23Specificity exchangers that redirect antibodies to bacterial adhesion receptors
#29 | 2005-06-09 ✅ Patent 7,307,066 granted on 2007-12-11Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
#30 | 2005-04-07 ✅ Patent 7,335,359 granted on 2008-02-26Glycosylated specificity exchangers
#31 | 2005-02-22 ✅ Patent 6,858,590 granted on 2005-02-22Vaccines containing ribavirin and methods of use thereof
#32 | 2005-01-27 ✅ Patent 7,318,926 granted on 2008-01-15Glycosylated specificity exchangers
234805 ⎘